March 02, 2021 NNVC 7:01 am ET NanoViricides Reports Positive Results for Covid-19 Drug Candidates Dow Jones 6:19 am ET NanoViricides Press Release Highlights 'strong pan-coronavirus effectiveness' Of Its NV-CoV-2 And NV-CoV-2-R Candidates; Says Both Candidates Were 'found to be highly effective in comparison to remdesivir against two distinctly different coronaviruses' Benzinga
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.